Tompkins Financial’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $274K | Buy |
+1,445
| New | +$272K | 0.02% | 173 |
|
|
2026
Q1 | – | Sell |
-1,260
| Closed | -$232K | – | 574 |
|
|
2025
Q4 | $232K | Buy |
1,260
+10
| +0.8% | +$1.75K | 0.02% | 184 |
|
|
2025
Q3 | $192K | Hold |
1,250
| – | – | 0.02% | 193 |
|
|
2025
Q2 | $175K | Hold |
1,250
| – | – | 0.02% | 198 |
|
|
2025
Q1 | $184K | Hold |
1,250
| – | – | 0.02% | 198 |
|
|
2024
Q4 | $164K | Hold |
1,250
| – | – | 0.02% | 203 |
|
|
2024
Q3 | $195K | Hold |
1,250
| – | – | 0.02% | 199 |
|
|
2024
Q2 | $195K | Buy |
+1,250
| New | +$188K | 0.02% | 202 |
|
|
2022
Q4 | – | Sell |
-96
| Closed | -$10K | – | 608 |
|
|
2022
Q3 | $10K | Hold |
96
| – | – | ﹤0.01% | 473 |
|
|
2022
Q2 | $13K | Sell |
96
-66
| -41% | -$8.66K | ﹤0.01% | 443 |
|
|
2022
Q1 | $21K | Hold |
162
| – | – | ﹤0.01% | 426 |
|
|
2021
Q4 | $19K | Hold |
162
| – | – | ﹤0.01% | 265 |
|
|
2021
Q3 | $19K | Buy |
+162
| New | +$18.9K | ﹤0.01% | 286 |
|
|
2021
Q1 | $16K | Hold |
162
| – | – | ﹤0.01% | 334 |
|
|
2020
Q4 | $16K | Hold |
162
| – | – | ﹤0.01% | 330 |
|
|
2020
Q3 | $18K | Hold |
162
| – | – | ﹤0.01% | 298 |
|
|
2020
Q2 | $17K | Hold |
162
| – | – | ﹤0.01% | 295 |
|
|
2020
Q1 | $14K | Sell |
162
-403
| -71% | -$37.9K | ﹤0.01% | 302 |
|
|
2019
Q4 | $56K | Sell |
565
-79
| -12% | -$7.44K | 0.01% | 246 |
|
|
2019
Q3 | $57K | Sell |
644
-209
| -25% | -$18.1K | 0.01% | 218 |
|
|
2019
Q2 | $70K | Hold |
853
| – | – | 0.01% | 211 |
|
|
2019
Q1 | $69K | Hold |
853
| – | – | 0.01% | 210 |
|
|
2018
Q4 | $65K | Sell |
853
-4
| -0.5% | -$312 | 0.01% | 211 |
|
|
2018
Q3 | $68K | Hold |
857
| – | – | 0.01% | 229 |
|
|
2018
Q2 | $60K | Buy |
857
+200
| +30% | +$14.4K | 0.01% | 239 |
|
|
2018
Q1 | $46K | Hold |
657
| – | – | 0.01% | 252 |
|
|
2017
Q4 | $45K | Sell |
657
-299
| -31% | -$20.2K | 0.01% | 233 |
|
|
2017
Q3 | $65K | Hold |
956
| – | – | 0.02% | 207 |
|
|
2017
Q2 | $65K | Hold |
956
| – | – | 0.02% | 201 |
|
|
2017
Q1 | $60K | Sell |
956
-106
| -10% | -$6.17K | 0.02% | 212 |
|
|
2016
Q4 | $58K | Hold |
1,062
| – | – | 0.02% | 206 |
|
|
2016
Q3 | $70K | Hold |
1,062
| – | – | 0.02% | 187 |
|
|
2016
Q2 | $64K | Sell |
1,062
-711
| -40% | -$41.3K | 0.02% | 221 |
|
|
2016
Q1 | $100K | Sell |
1,773
-761
| -30% | -$45.7K | 0.03% | 190 |
|
|
2015
Q4 | $172K | Hold |
2,534
| – | – | 0.05% | 167 |
|
|
2015
Q3 | $161K | Sell |
2,534
-988
| -28% | -$65K | 0.05% | 166 |
|
|
2015
Q2 | $224K | Sell |
3,522
-300
| -8% | -$20.5K | 0.06% | 153 |
|
|
2015
Q1 | $261K | Sell |
3,822
-158
| -4% | -$11K | 0.07% | 150 |
|
|
2014
Q4 | $280K | Sell |
3,980
-1,732
| -30% | -$124K | 0.07% | 146 |
|
|
2014
Q3 | $408K | Buy |
5,712
+968
| +20% | +$70.9K | 0.11% | 123 |
|
|
2014
Q2 | $353K | Sell |
4,744
-12,240
| -72% | -$885K | 0.09% | 136 |
|
|
2014
Q1 | $1.1M | Buy |
16,984
+1,185
| +8% | +$76.5K | 0.28% | 77 |
|
|
2013
Q4 | $938K | Buy |
15,799
+2,813
| +22% | +$153K | 0.24% | 85 |
|
|
2013
Q3 | $675K | Buy |
12,986
+1,465
| +13% | +$73.6K | 0.19% | 99 |
|
|
2013
Q2 | $545K | Buy |
+11,521
| New | +$587K | 0.16% | 103 |
|
Other funds holding AZN
EP
IA
Tompkins Financial's AZN Position: Q2 2026 in Review
Tompkins Financial opened a new position in AstraZeneca (AZN) in Q2 2026: 1,445 shares worth $274K. The stake represents 0.02% of the portfolio and ranks #173 among its holdings. This is a return to the name: Tompkins Financial previously reported a position in AZN as recently as Q4 2025.
Tompkins Financial first reported a position in AZN in Q2 2013 and has held it in 45 quarters since. The position peaked at $1.1M in Q1 2014. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Tompkins Financial held 1,445 shares of AstraZeneca worth $274K as of Q2 2026.
- AstraZeneca was a new Tompkins Financial position in Q2 2026.
- AstraZeneca made up 0.02% of Tompkins Financial's portfolio in Q2 2026, its #173 holding.
- Tompkins Financial first reported a position in AstraZeneca in Q2 2013 and has held it in 45 quarters since.
- Tompkins Financial's AstraZeneca position peaked at $1.1M in Q1 2014.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Tompkins Financial's 13F filing for Q2 2026, filed 15 Jul 2026.